ESR2 and neoplasm: Therefore, we next determined whether we could achieve in vivo efficacy using naïve effector cells, and furthermore, if the presence of the CAR on multiple immune subsets would enable them to coordinate and mount an effective immune response in vivo against a tumor expressing the ERB antigen.